Who Gets Health in Old Age?September 20, 2017 |
Rich, White People. Access to insurance isn’t erasing race- and class-based health disparities
Quick Read
They want insurers to re-examine coverage policies that, as ProPublica and The New York Times reported Sunday, may be driving patients toward addictive painkillers
Quick Read
An obscure Obamacare provision forces rural hospitals to pay full price for drugs that many bigger hospitals buy at deeply discounted rates
Quick Read
Amid Opioid Crisis, Insurers Restrict Pricey, Less Addictive PainkillersSeptember 18, 2017 |
Drug companies and doctors have been accused of fueling the opioid crisis, but some question whether insurers have played a role, too
Quick Read
Who Will Build the Health-Care Blockchain?September 15, 2017 |
Decentralized databases promise to revolutionize medical records, but not until the health-care industry buys in to the idea and gets to work
Quick Read
Although vaccines typically take years to produce, test, and license, US health officials had voiced confidence that Zika would not be a difficult target, and some predicted that a vaccine could be made and fully tested, ready for FDA assessment, within two to three years. Others predicted a licensed Zika vaccine could be available sometime in 2020
Quick Read
New Gene-Therapy Treatments Will Carry Whopping Price TagsSeptember 12, 2017 |
The first gene therapy treatment in the United States was approved recently by the Food and Drug Administration, heralding a new era in medicine that is coming faster than most realize — and that perhaps few can afford
Quick Read
This Shield of Patents Protects the World’s Best-Selling DrugSeptember 8, 2017 |
Over Humira’s lifetime, AbbVie has secured more than 100 patents to prevent anyone from attempting to copy the biologic, with $16 billion in annual sales
Quick Read